You are wrong. Big pharm is in the wings, IMO. Scarlett is "giddy" and may be getting "greedy". We know he is supposed to be a tough negotiator, hired to sell the company or find a strong partner. This will be resolved, at the latest by Valentine Day (probably before). Imetelstat, IMO, is a miracle-drug. Patience seems the best approach, as long as all of the good features of Imetelstat hold, as revealed at ASH by Mayo.